FDA Import Refusal 1FX-3997052-1/80002/1 — CAPLIN POINT
The FDA refused shipment 1FX-3997052-1/80002/1 from CAPLIN POINT (Guatemala) on September 15, 2026. The refused product falls under Drugs and Biologics — IBUPROFEN (ANTI-INFLAMMATORY). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- September 15, 2026
- Country
- Guatemala
- Product Category
- Drugs and Biologics
- Product Code
- 62GCY41 IBUPROFEN (ANTI-INFLAMMATORY)
- Charges
- 75